VIRGINIA NATIONAL BANKSHARES CORPORATION

VABK

CIK 0001572334 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$20M
↑+1.7% +$335Kvs FY2024 (Q4)
Operating Income
$19M
↑+2.0% +$382Kvs FY2024 (Q4)
Net Income
$6M
↑+30.6% +$1Mvs FY2024 (Q4)
Gross Profit
$20M
↑+1.7% +$335Kvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
4/100
  • Profitability
    0Insufficient data
  • Liquidity
    0Insufficient data
  • Leverage
    0Insufficient data
  • Efficiency
    0Asset Turnover 0.05x (1.0+ = capital-efficient)
  • Growth
    22Revenue YoY +1.7% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project VABK's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -2.1%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$53.47
Total enterprise IV
$290M
Diluted shares
0.01B
Terminal PV
$204M (70% of total)
Year-5 FCF
$24M
YearProjected FCFDiscounted PV
+1$21M$19M
+2$22M$18M
+3$23M$17M
+4$23M$16M
+5$24M$15M
Terminal$329M$204M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$649K
investment in PP&E
Stock buybacks (TTM)
$0
share count reduction

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$1.65B
everything owned
Total liabilities
$1.47B
everything owed
Stockholders' equity
$184M
shareholder claim

Recent performance · 52 quarters

Revenue↑+1.7% +$335K
$20M
Net Income↑+30.6% +$1M
$6M
Free Cash Flow↑+94.1% +$3M
$6M

Drill down